News

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.
Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real ...